Navigation Links
Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Date:8/8/2008

EAST SETAUKET, N.Y., Aug. 8 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that lead compounds from each of two different types of drugs being developed as potential treatment for specific types of brain cancers have activity against human pancreatic cancers in a mouse model.

Dr. John S. Kovach, President and CEO of Lixte, said, "Lixte previously reported that lead compounds from each of two different classes of pharmacologic agents have significant inhibitory activity against several types of human cancers in the test tube and against brain cancers in animal models. We have now found that two different lead compounds also have statistically significant activity against human pancreatic cancer cells growing in mice. These are early studies and there is no evidence that these drugs are able to eliminate pancreatic cancers but rather slow their growth. We are encouraged, however, that two classes of our drugs have activity against this devastating cancer in addition to glioblastoma multiforme, the most common and most malignant form of brain cancer."

About Lixte Biotechnology Holdings, Inc.:

Lixte Biotechnology Holdings, Inc. is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, Lixte develops new chemotherapy drugs targeting molecular abnormalities of common human cancers.

Forward-Looking Statements:

This announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. For example, statements regarding the Company's financial position, business strategy and other plans and objectives for future operations, and assumptions and predictions about future product demand, supply, manufacturing, costs, marketing and pricing factors are all forward-looking statements. These statements are generally accompanied by words
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
2. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
3. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
4. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
5. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
6. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
7. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
8. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Levi & Korsinsky is investigating ... "the Company") (NasdaqGS: SIAL ) for possible ... law in connection with the sale of the Company ... to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199 , ... to you. Under the terms of the ...
(Date:9/22/2014)... , Sept. 22, 2014 The western ... stage. It is largely a replacement market with ... The mergers, acquisitions and partnerships are redefining competitive ... This research service provides details about revenue forecasts, ... pricing trends across the country. The changing landscape ...
(Date:9/22/2014)... Sept. 22, 2014 Research and Markets ... for Neurotechnology: 2014-2018" report to their offering. ... the most comprehensive and up-to-date publication available covering the ... the technology, markets, competitors, and growth rates in four ... 2014 through 2018. It forecasts the number of systems ...
Breaking Medicine Technology:SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL 2Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3The Market for Neurotechnology: 2014-2018 2
... SILVER SPRING, Md., Sept. 30 The U.S. ... companies that manufacture, distribute, and/or market unapproved single-ingredient ... daily prevention of gout, to treat acute gout ... Fever (FMF). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ...
... disease who used once-daily Neupro® (rotigotine) in the ... in addition to previously reported beneficial effects on ... this week at the 2nd World Parkinson Congress ... relevant improvements in PDQ-8 score. This is a ...
Cached Medicine Technology:FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine 2FDA Orders Halt to Marketing of Unapproved Single-Ingredient Oral Colchicine 3Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 2Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 3Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 4Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 5Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 6Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease 7
(Date:9/22/2014)... leather seat covers offered by Lseat.com are meticulously in ... to meet customers’ specific product needs and budget level. The ... leather seat covers . Furthermore, the firm has launched an ... the new range is now available at a discounted rate ... are produced, the company’s top designers also carefully pick out ...
(Date:9/22/2014)... Fashion Footwear Association of New York (FFANY) and leading ... research to the University of Pittsburgh Cancer Institute (UPCI), ... the proceeds of the 20th annual QVC Presents "FFANY ... several cancer research centers across the country, including UPCI ... has been selected to receive funds from this year,s ...
(Date:9/22/2014)... September 22, 2014 On Saturday, September 27, ... Playworks, a local nonprofit that is doing an amazing job ... including UHY employees, their families and friends will be spending ... paint on cement games and graphics, as well as clean ... was originally scheduled to occur in May but due to ...
(Date:9/22/2014)... and young adults at risk for sexually transmitted infections ... sexual behaviors, according to new recommendations from the U.S. ... million new sexually transmitted infections such as gonorrhea and ... people between 15 and 24 years old, according to ... Sept. 22 in Annals of Internal Medicine , ...
(Date:9/22/2014)... By Amy Norton ... -- Tiny preemies may fare better when newborn intensive care ... time with their infants, a new study finds. Researchers ... were more alert and were less distressed when their NICU ... families. The findings, published online Sept. 22 in the ...
Breaking Medicine News(10 mins):Health News:Great 2007-2012 Jeep Wrangler JK Real Leather Seat Covers Introduced by Lseat.com 2Health News:Heels for a cause: FFANY, QVC Present $240,000 from shoe sales to Pitt researchers 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3
... Results from the first,quantitative study measuring tobacco ... Comunidades Latinas Unidas En Servicio (CLUES), Blue,Cross and ... Minnesota(SM).,The report, titled "Tobacco Use in Minnesota: A ... adult Latinos overall are smoking at,a rate lower ...
... The holidays can become,stressful for many families -- the pressure ... friends, relatives and co-workers, and, this,year, the added weight of ... look to give the gift of companionship and joy by ... "Before giving a furry friend as ...
... confirmation of Sam Smith as the new Chief Executive Officer of ... Committee of the International Board of Directors on Tuesday. , ... ... announced today the unanimous confirmation of Sam Smith as the new ...
... of pre-screened,Greater China suppliers hope to end the ... Global Sources, (Nasdaq: GSOL ) December ... sanitaryware & plumbing; bathroom,& cleaning accessories; computer monitors, ... personal care products. , ...
... Commitment to GAC,s Work Advocating for Orphans and Highly ... , WASHINGTON, Dec. 4 Today, Global ... the Jolie-Pitt Foundation. The grant will support GAC,s ... Children (EPIWC) in the new Obama administration, ensure children ...
... Dec. 3 In recognition of the value the American ... to honor George Buchanan, M.D., and Timothy J. Ley, M.D., ... play in the training and professional development of hematologists early ... Each year, two awardees -- one from the discipline of ...
Cached Medicine News:Health News:New Tobacco Research Finds Minnesota's Latino Population Smoking Significantly Less than General Population 2Health News:New Tobacco Research Finds Minnesota's Latino Population Smoking Significantly Less than General Population 3Health News:New Tobacco Research Finds Minnesota's Latino Population Smoking Significantly Less than General Population 4Health News:New Tobacco Research Finds Minnesota's Latino Population Smoking Significantly Less than General Population 5Health News:A Season of Responsibility for New Pet Owners 2Health News:New CEO Takes Helm at Mercy Ships 2Health News:New CEO Takes Helm at Mercy Ships 3Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 2Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 3Health News:Greater China suppliers set to end tough 2008 with strong buyer activity at Global Sources' Private Sourcing Events 4Health News:Jolie-Pitt Foundation Awards Second Grant to Global Action for Children 2Health News:Inspirational Hematologists Honored With Mentor Awards From the American Society of Hematology 2
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
Vertical punch designed to create a 1.5mm clean cylindrical hole. Rotatable for convenient positioning. Flat Handle. Overall length 87mm....
... neck. Piston assembly fits into neck ... to recoil back to ready position ... precision milled cavity in platform. Accepts ... 9.0mm. Designed for the preparation of ...
Medicine Products: